Terms: = Lung cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Staging
42 results:
1. Prognostic nomograms for breast cancer with lung metastasis: a SEER-based population study.
Xie Y; Lei C; Ma Y; Li Y; Yang M; Zhang Y; Law KN; Wang N; Qu S
BMC Womens Health; 2024 Jan; 24(1):16. PubMed ID: 38172874
[TBL] [Abstract] [Full Text] [Related]
2. Incidental irradiation of the regional lymph nodes during deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a dosimetric analysis.
Wolf J; Kurz S; Rothe T; Serpa M; Scholber J; Erbes T; Gkika E; Baltas D; Verma V; Krug D; Juhasz-Böss I; Grosu AL; Nicolay NH; Sprave T
BMC Cancer; 2022 Jun; 22(1):682. PubMed ID: 35729505
[TBL] [Abstract] [Full Text] [Related]
3. The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein.
Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ
Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological features and prognosis of male breast cancer.
Wang X; Liu S; Xue Y
J Int Med Res; 2021 Oct; 49(10):3000605211049977. PubMed ID: 34713754
[TBL] [Abstract] [Full Text] [Related]
5. Clinical features of patients with her2-positive breast cancer and development of a nomogram for predicting survival.
Fan Y; Wang Y; He L; Imani S; Wen Q
ESMO Open; 2021 Aug; 6(4):100232. PubMed ID: 34392135
[TBL] [Abstract] [Full Text] [Related]
6. Establishment and Validation of Nomogram Model Integrated With Inflammation-Based Factors for the Prognosis of Advanced Non-Small Cell lung cancer.
Huang Z; Xing S; Zhu Y; Qu Y; Jiang L; Sheng J; Wang Q; Xu S; Xue N
Technol Cancer Res Treat; 2020; 19():1533033820971605. PubMed ID: 33191854
[TBL] [Abstract] [Full Text] [Related]
7. Molecular analysis in cytological samples obtained by endobronchial or oesophageal ultrasound guided needle aspiration in non-small cell lung cancer.
Centeno C; Serra Mitja P; Avila M; Carcereny E; Muñoz-Mármol AM; Moran T; Castellà E; Sanz-Santos J; García Olivé I; Ramirez Serrano JL; Rosell Gratacos A; Andreo García F
Pulmonology; 2022; 28(1):28-33. PubMed ID: 32507497
[TBL] [Abstract] [Full Text] [Related]
8. Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer.
van Uden DJP; van Maaren MC; Strobbe LJA; Bult P; van der Hoeven JJ; Siesling S; de Wilt JHW; Blanken-Peeters CFJM
Breast Cancer Res; 2019 Oct; 21(1):113. PubMed ID: 31623649
[TBL] [Abstract] [Full Text] [Related]
9. Methylation of Glutathione-S-Transferase P1 Promotor in Egyptian Females with Breast cancer.
Moghazy TF; ElAttar HA; Eldeeb MK; Rashad RM; Farouk AM; Farag AM
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2523-2530. PubMed ID: 31450928
[TBL] [Abstract] [Full Text] [Related]
10. staging of nutrition disorders in non-small-cell lung cancer patients: utility of skeletal muscle mass assessment.
Antoun S; Morel H; Souquet PJ; Surmont V; Planchard D; Bonnetain F; Foucher P; Egenod T; Krakowski I; Gaudin H; Debieuvre D
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):782-793. PubMed ID: 30932365
[TBL] [Abstract] [Full Text] [Related]
11. A critical review of the chest CT scans performed to detect asymptomatic synchronous metastasis in new and recurrent breast cancers.
James J; Teo M; Ramachandran V; Law M; Stoney D; Cheng M
World J Surg Oncol; 2019 Feb; 17(1):40. PubMed ID: 30797241
[TBL] [Abstract] [Full Text] [Related]
12. Population-based validation of the National cancer Comprehensive Network recommendations for breast cancer staging.
Abdel-Rahman O
Breast Cancer Res Treat; 2018 Nov; 172(1):231-238. PubMed ID: 30022329
[TBL] [Abstract] [Full Text] [Related]
13. New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes.
Buonomo OC; Caredda E; Portarena I; Vanni G; Orlandi A; Bagni C; Petrella G; Palombi L; Orsaria P
PLoS One; 2017; 12(9):e0184680. PubMed ID: 28922402
[TBL] [Abstract] [Full Text] [Related]
14. [Establishment of cut-off value of serum pro-gastrin-releasing peptide for diagnosis of small cell lung cancer and evaluation on the clinical diagnosis efficiency].
Shen D; Han BB; Chen F; Wei BJ; Cui CJ; Wang GJ; Cui W
Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2657-2662. PubMed ID: 28910952
[No Abstract] [Full Text] [Related]
15. [Clinicopathological and prognostic significance of a panel of tumor biomarkers in lung adenocarcinoma: a tissue microarray study].
Yang X; Xue L; Guo L; Wen P; Lin D
Zhongguo Fei Ai Za Zhi; 2014 Mar; 17(3):243-53. PubMed ID: 24667263
[TBL] [Abstract] [Full Text] [Related]
16. Baseline staging tests based on molecular subtype is necessary for newly diagnosed breast cancer.
Chen X; Sun L; Cong Y; Zhang T; Lin Q; Meng Q; Pang H; Zhao Y; Li Y; Cai L; Dong X
J Exp Clin Cancer Res; 2014 Mar; 33(1):28. PubMed ID: 24628817
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic and predictive biomarkers in lung cancer. A review.
Thunnissen E; van der Oord K; den Bakker M
Virchows Arch; 2014 Mar; 464(3):347-58. PubMed ID: 24420742
[TBL] [Abstract] [Full Text] [Related]
18. ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.
Zhang Y; Sun Y; Li Y; Fang Z; Wang R; Pan Y; Hu H; Luo X; Ye T; Li H; Wang L; Chen H; Ji H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S577-82. PubMed ID: 23775406
[TBL] [Abstract] [Full Text] [Related]
19. Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer.
Koolen BB; van der Leij F; Vogel WV; Rutgers EJ; Vrancken Peeters MJ; Elkhuizen PH; Valdés Olmos RA
Acta Oncol; 2014 Jan; 53(1):50-7. PubMed ID: 23672678
[TBL] [Abstract] [Full Text] [Related]
20. Update on clinical trials: genetic targets in breast cancer.
Lim B; Cream LV; Harvey HA
Adv Exp Med Biol; 2013; 779():35-54. PubMed ID: 23288634
[TBL] [Abstract] [Full Text] [Related]
[Next]
